Visit the 2014 website now!

29-30 January 2013, San Francisco

Arena International’s Outsourcing in Clinical Trials, West Coast conference aims to formulate a more proactive approach to perfecting Sponsor-Vendor relationships.

Outsourcing has quickly established itself as an intrinsic accomplice to biopharmaceutical companies and Outsourcing in Clinical Trials West Coast is here to necessitate this demand.

It has been estimated that outsourcing levels will rise to 10-15 per cent of the pharmaceutical industry’s total annual spend of US$490-670 billion. This exemplifies the importance of good CRO governance and fluid trial management and redefines how crucial it is to the trial process.

Outsourcing in Clinical Trials West Coast aims to qualify the skyrocketing importance of strategic vendor selection and management as well as incorporate key changes and advancements within the industry on a national and global scale. The conference will document the level of growth in new markets and show how this approach helps boost productivity and provide our delegates with a unique and comprehensive experience.

The 5th annual Outsourcing in Clinical Trials West Coast conference will explore varied techniques and strategies on how best to maintain consistency and quality and create value for your stock holders.



Delhi to examine 'weak regulation' of clinical trials

Trial and Error - Part 3: Indian authorities admit to the failings exposed by The Independent’s investigation into drug tests.

Drugmakers and antibiotics; The path of least resistance

Governments reckon that drug firms’ research efforts need a shot in the arm.

Analysis: Big Pharma gets a driving lesson from carmakers

(Reuters) - Big drugmakers, under pressure to streamline operations in the face of rising costs and slowing sales, are looking to the automotive industry for tips ontuning up their profit engines.


Speakers Include

Indra Aboltina

CEO, Member of the Board, Dokumeds

Nadia Bracken

Clinical Program Manager, Biotie Therapies

Sponsored by


Sponsored by

CFS Clinical

Chris Chan

Senior Director, Clinical Finance, Fibrogen

Harinder Chera

Director Clinical Operations, Onyx Pharmaceuticals

Nicole Christison

Consultant Project Manager, PSI

Diana Chung

Associate Director, Clinical Operations, Gilead Sciences

Scott Connor

Vice President, Marketing, Acurian

Laurence Corash

Chief Medical Officer, Cerus

Pierre Corin

Senior Director Development Operations, Cerexa

Davin Dillon

Senior Director, Program management, Nektar Therapeautics

Barbara Elashoff

CEO, Patient Profiles

Christina Fleming PhD

Chief Scientific Officer, Advanced Clinical

Monica Gangal

Director, Clinical Operations, Anthera Pharmaceuticals

Spencer Guthrie

Senior Director, Clinical Operations and Program leader, Ultragenyx Pharmaceuticals

Darren Hart

Vice President, Clinical Operations and Biometrics, Elan Pharmaceuticals

Eric Humphriss

Senior Director, Versartis

Richard Koenig

Vice President Operations, Clinstar